Skip to main content
Premium Trial:

Request an Annual Quote

Trial Data Release Push

Asset managers are teaming up with a UK nonprofit campaign to get drug companies to release their clinical trial data, reports Ed Silverman over at Pharmalot.

He notes that this group of 85 asset and pension managers — who manage a total $3.8 trillion — plans to meet with drug makers in which they invest to convince them to register their clinical trials and report results. This is in conjunction with Sense About Science's AllTrials campaign in the UK that aims to encourage greater transparency and enable independent researchers to verify results, Silverman adds.

Recently, he says, there have been concerns that trial data for some products haven't fully published or disclosed. Though some companies have begun to release trial data, critics say such efforts are rare.

Helena Vines Fiestas, the head of sustainability research at BNP Paribas Investment Partners, tells Pharmalot that such opacity affects not only decisions made by regulators and physicians, but also investors.

"We think if the companies become more transparent and take the issue around auditing and reports more seriously that the decisions made by analysts can be more closely aligned with reality," she adds.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.